These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34420030)

  • 21. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
    Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy.
    Neyazi A; Theilmann W; Brandt C; Rantamäki T; Matsui N; Rhein M; Kornhuber J; Bajbouj M; Sperling W; Bleich S; Frieling H; Löscher W
    Transl Psychiatry; 2018 Jan; 8(1):25. PubMed ID: 29353887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder.
    Saghafi R; Brown C; Butters MA; Cyranowski J; Dew MA; Frank E; Gildengers A; Karp JF; Lenze EJ; Lotrich F; Martire L; Mazumdar S; Miller MD; Mulsant BH; Weber E; Whyte E; Morse J; Stack J; Houck PR; Bensasi S; Reynolds CF
    Int J Geriatr Psychiatry; 2007 Nov; 22(11):1141-6. PubMed ID: 17486678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression biomarkers of response to citalopram treatment in major depressive disorder.
    Mamdani F; Berlim MT; Beaulieu MM; Labbe A; Merette C; Turecki G
    Transl Psychiatry; 2011 Jun; 1(6):e13. PubMed ID: 22832429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic predictors of remission to antidepressant treatment in geriatric depression using genome-wide expression analyses: a pilot study.
    Eyre HA; Eskin A; Nelson SF; St Cyr NM; Siddarth P; Baune BT; Lavretsky H
    Int J Geriatr Psychiatry; 2016 May; 31(5):510-7. PubMed ID: 26471432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?
    Montgomery SA; Möller HJ
    Int Clin Psychopharmacol; 2009 May; 24(3):111-8. PubMed ID: 19357527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early changes of serum BDNF and SSRI response in adolescents with major depressive disorder.
    Lee J; Lee KH; Kim SH; Han JY; Hong SB; Cho SC; Kim JW; Brent D
    J Affect Disord; 2020 Mar; 265():325-332. PubMed ID: 32090756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.
    Moore N; Verdoux H; Fantino B
    Int Clin Psychopharmacol; 2005 May; 20(3):131-7. PubMed ID: 15812262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of age on paroxetine efficacy in patients with major depressive disorder who do not exhibit an early response to treatment.
    Tomita T; Sato Y; Nakagami T; Tsuchimine S; Kaneda A; Kaneko S; Nakamura K; Yasui-Furukori N
    Clin Neuropharmacol; 2015; 38(1):6-10. PubMed ID: 25580920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features and drug induced side effects in early versus late antidepressant responders.
    Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A
    J Psychiatr Res; 2013 Oct; 47(10):1309-18. PubMed ID: 23800418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
    Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
    CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Machine Learning Analysis of Blood microRNA Data in Major Depression: A Case-Control Study for Biomarker Discovery.
    Qi B; Fiori LM; Turecki G; Trakadis YJ
    Int J Neuropsychopharmacol; 2020 Nov; 23(8):505-510. PubMed ID: 32365192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of hedonic perception of odors as a marker of treatment response to escitalopram: olfactory changes through an open-label antidepressant trial.
    Kazour F; Atanasova B; Desmidt T; Gissot V; Lefevre A; Camus V; Belzung C; El-Hage W
    Braz J Psychiatry; 2023; 45(5):414-422. PubMed ID: 37718120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.
    Pennybaker SJ; Niciu MJ; Luckenbaugh DA; Zarate CA
    J Affect Disord; 2017 Jan; 208():560-566. PubMed ID: 27839782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
    J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-omic modeling of antidepressant response implicates dynamic immune and inflammatory changes in individuals who respond to treatment.
    Fuh SC; Fiori LM; Turecki G; Nagy C; Li Y
    PLoS One; 2023; 18(5):e0285123. PubMed ID: 37186582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.
    Lepola U; Wade A; Andersen HF
    Int Clin Psychopharmacol; 2004 May; 19(3):149-55. PubMed ID: 15107657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.
    Power RA; Muthén B; Henigsberg N; Mors O; Placentino A; Mendlewicz J; Maier W; McGuffin P; Lewis CM; Uher R
    J Psychiatr Res; 2012 Oct; 46(10):1333-8. PubMed ID: 22770672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report.
    Allen TA; Lam RW; Milev R; Rizvi SJ; Frey BN; MacQueen GM; Müller DJ; Uher R; Kennedy SH; Quilty LC
    Psychol Med; 2019 Jul; 49(10):1629-1638. PubMed ID: 30220263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.